Quick Answer
ASSEMBLY BIOSCIENCES, INC. reported Research And Development Expense of $64.81 million for the year ending 2025.
- ASSEMBLY BIOSCIENCES, INC. showed an increase of +15.9% in Research And Development Expense from 2024 to 2025.
- This data is from ASSEMBLY BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $193.2 thousand | Q1 2011: $970.8 thousand | Q2 2011: $3.10 million | Q3 2011: $3.67 million | Q1 2012: $6.42 million | Q2 2012: $6.16 million | Q3 2012: $4.19 million | Q1 2013: $2.61 million | Q2 2013: $3.51 million | Q3 2013: $3.75 million | Q1 2014: $2.97 million | Q2 2014: $1.10 million | Q3 2014: $3.67 million | Q1 2015: $3.83 million | Q2 2015: $4.67 million | Q3 2015: $4.63 million | Q1 2016: $8.12 million | Q2 2016: $7.52 million | Q3 2016: $8.83 million | Q1 2017: $10.57 million | Q2 2017: $12.13 million | Q3 2017: $10.93 million | Q1 2018: $14.54 million | Q2 2018: $17.84 million | Q3 2018: $19.11 million | Q1 2019: $22.70 million | Q2 2019: $18.70 million | Q3 2019: $21.74 million | Q1 2020: $23.05 million | Q2 2020: $23.33 million | Q3 2020: $26.94 million | Q1 2021: $18.55 million | Q2 2021: $16.75 million | Q3 2021: $18.47 million | Q1 2022: $17.21 million | Q2 2022: $17.79 million | Q3 2022: $18.13 million | Q1 2023: $14.55 million | Q2 2023: $12.52 million | Q3 2023: $10.82 million | Q1 2024: $11.88 million | Q2 2024: $16.26 million | Q3 2024: $13.52 million | Q1 2025: $14.85 million | Q2 2025: $16.13 million | Q3 2025: $16.59 million.
- Over the full 17 years of available data (2009 to 2025), ASSEMBLY BIOSCIENCES, INC.'s Research And Development Expense has grown by 2,102.3%.
- Historical annual values: Fiscal year 2025: $64.81 million | Fiscal year 2024: $55.93 million | Fiscal year 2023: $48.90 million | Fiscal year 2022: $69.98 million | Fiscal year 2021: $68.52 million | Fiscal year 2020: $106.82 million | Fiscal year 2019: $85.76 million | Fiscal year 2018: $72.74 million | Fiscal year 2017: $44.23 million | Fiscal year 2016: $33.09 million | Fiscal year 2015: $18.36 million | Fiscal year 2014: $10.72 million | Fiscal year 2013: $4.58 million | Fiscal year 2012: $19.51 million | Fiscal year 2011: $25.28 million | Fiscal year 2010: $1.85 million | Fiscal year 2009: $2.94 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: